Association between body mass index (BMI) and markers of eosinophilic inflammation in asthma

R. Berair, V. Mistry, A. Singapuri, S. Gonem, C. Newby, S. Siddiqui, R. Kay, C. Brightling (Leicester, United Kingdom; Basel, Switzerland)

Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Session: New mechanisms in the pathogenesis of asthma and other lung diseases
Session type: Thematic Poster Session
Number: 3870
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Berair, V. Mistry, A. Singapuri, S. Gonem, C. Newby, S. Siddiqui, R. Kay, C. Brightling (Leicester, United Kingdom; Basel, Switzerland). Association between body mass index (BMI) and markers of eosinophilic inflammation in asthma. Eur Respir J 2014; 44: Suppl. 58, 3870

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Association between airway inflammation, airway remodelling and physiological changes in asthma
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014


MIP-1β is associated with eosinophilic airway inflammation
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016


Serum periostin in obstructive airways disease: Range, relationships and response to corticosteroid
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014


The airway microbiota is significantly altered in subjects with eosinophilic asthma
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014

Airway remodeling and eosinophilic asthma
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013

Comparison of inflammatory markers in induced and spontaneous sputum in COPD patients
Source: International Congress 2014 – Translational studies in COPD
Year: 2014

Effects of aerobic training on perivascular inflammation and on vascular activation in a model of asthma
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014

Body mass index and adipose tissue within the airway wall
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016

Disturbed pulmonary immunity and the phenotype of alveolar macrophages in bronchial asthma, gastroesophageal reflux disease and their combination
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014

Humoral immunity parameters in smoking and non-smoking patients with COPD
Source: International Congress 2014 – Translational studies in COPD
Year: 2014


Airway inflammation in patients with different levels of asthma control
Source: Annual Congress 2013 –Asthma: new mechanisms and markers
Year: 2013


Blood cytotoxic/pro-inflammatory mediators in severe asthma
Source: International Congress 2014 – TH17 and other acute asthmatic responses
Year: 2014

Imbalance of immune response functional phenotype and alveolar macrophages phenotype in COPD
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014


Omalizumab prevents smooth muscle cell growth induced by asthmatic serum
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014


Body mass impacts distal airway function
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014


Influence of ADRβ2 gene polymorphism on the level of bronchial obstruction and body mass index in patients with bronchial asthma
Source: International Congress 2016 – Role of genetics and exposures in COPD and asthma
Year: 2016


Association between cardio-ankle vascular index (CAVI) and chronic airway obstruction in asthma
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016

Discrimination of bronchial inflammatory phenotype of asthmatic patients by using the electronic nose
Source: Annual Congress 2013 –Origins and diagnosis of asthma
Year: 2013



Modulation of inflammation by benralizumab in eosinophilic airway disease
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016


Influence of body mass index on asthma severity and control: A cross-sectional study
Source: Annual Congress 2013 –Disease control and quality of life in airway diseases
Year: 2013